Hemodynamic and Clinical Outcomes of Milrinone Compared to Dobutamine in Cardiogenic Shock: A-Systematic Review and Meta-Analysis
Abstract
Background
Despite years of clinical experience with the two most commonly used inotropes i.e dobutamine and milrinone, in the cardiogenic shock setting, there is a lack of head-to-head comparison between inotropes in cardiogenic shock. We conducted a systematic review and meta-analysis on the comparison of hemodynamic and clinical effects of dobutamine and milrinone in cardiogenic shock.
Methods
A comprehensive literature search using PubMed and Scopus was performed. Among 40 studies retrieved from the database, 3 studies were included for hemodynamic comparison outcome and 2 studies for clinical outcomes.
Results
Three studies with 101 patients were included for hemodynamic analysis and two studies with 146 patients for clinical analysis. We observed no significant difference between cardiac index, pulmonary capillary wedge pressure, and mean arterial pressure at 1 hour after milrinone and dobutamine administration. However, there is significantly lower mPAP after milrinone infusion compared to dobutamine (mean difference -8,7 (-9,97 to -7,43) mmHg, p<0,01). We also observed no significant difference in in-hospital mortality but significantly shorter ICU length of stay in the milrinone group (mean difference -1 (-1,92 to -0,08) days).
Conclusion
Administration of milrinone resulted in lower PA pressure and shorter ICU LOS compared to dobutamine in patients with cardiogenic shock.
Downloads
References
2. Maeda K, Takanashi S, Saiki Y. Perioperative use of the intra-aortic balloon pump: Where do we stand in 2018? Vol. 33, Current Opinion in Cardiology. Lippincott Williams and Wilkins; 2018. p. 613–21.
3. Kalmanovich E, Audurier Y, Akodad M, Mourad M, Battistella P, Agullo A, et al. Management of advanced heart failure: a review. Vol. 16, Expert Review of Cardiovascular Therapy. Taylor and Francis Ltd; 2018. p. 775–94.
4. Mathew R, Santos GM, Visintini SM, Daniel F, Ramirez F, Disanto P, et al. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis. Vol. 42, Clin Invest Med •. 2019.
5. Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The precedent study. American Heart Journal. 2002 Dec 1;144(6):1102–8.
6. Mathew R, di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, et al. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. New England Journal of Medicine. 2021 Aug 5;385(6):516–25.
7. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic Shock. 1999.
8. Jentzer JC, Coons JC, Link CB, Schmidhofer M. Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit. Vol. 20, Journal of Cardiovascular Pharmacology and Therapeutics. SAGE Publications Ltd; 2015. p. 249–60.
9. Zimmerman J, Lee JP, Cahalan M. Vasopressors and inotropes. In: Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. Elsevier; 2018. p. 520–34.
10. Ayres JK, Maani CV. Milrinone [Internet]. Vol. 1. 2021 [cited 2022 Feb 16]. 2–3 p. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532943/
Full Text (PDF) downloads: 888
Copyright (c) 2023 Indonesian Journal of Cardiology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
